Company intelligence / Profile preview

10x Genomics

Pleasanton, California, United States10xgenomics.com ↗

Ownership: Public · TXG
Employees: ~1350
Development stage: Commercial

Overview

10x Genomics is a leading developer of single-cell and spatial genomics platforms used by academic and biopharma researchers globally. Its technologies have enabled over 8,200 publications across diverse fields such as oncology, immunology, neuroscience. The company continues to expand its product portfolio with new launches like GEM-X Flex and Xenium Prime panels in 2024.

Modalities: DeviceSoftware
Industry: Non-Drug Biotech

Partnerships

Everlife-Lifeline distribution partnership in the Philippinesvarious collaborations with academic institutions

Financials

Market cap: $8.3B
Total revenue: $151M
Enterprise value: $7.9B

Beyond the preview

Go deeper on 10x Genomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 10x Genomics.

Explore the full profile